Emvita 6

Active substance: ARSENIC TRIOXIDE, SUS SCROFA ADRENAL GLAND, LACHESIS MUTA VENOM, PHOSPHORUS, CLAVICEPS PURPUREA SCLEROTIUM

LIQUID · ARSENIC TRIOXIDE 18 [hp_M]/60mL, SUS SCROFA ADRENAL GLAND 21 [hp_X]/60mL, LACHESIS MUTA VENOM 21 [hp_X]/60mL, PHOSPHORUS 800 [hp_C]/60mL, CLAVICEPS PURPUREA SCLEROTIUM 16 [hp_M]/60mL

United StatesActive

Marketing holder: RUBIMED AG

Verified 2026-10-09 · openFDA NDC

Analogues in other countries

Source: openFDA NDC
Countries with the substance registered: 2

Composition

ARSENIC TRIOXIDE · 18 [hp_M]/60mL
SUS SCROFA ADRENAL GLAND · 21 [hp_X]/60mL
LACHESIS MUTA VENOM · 21 [hp_X]/60mL
PHOSPHORUS · 800 [hp_C]/60mL
CLAVICEPS PURPUREA SCLEROTIUM · 16 [hp_M]/60mL

Products containing arsenic trioxide in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

Country	Products
EU 4	Arsenic trioxide Accord arsenic trioxide EMEA/H/C/005175 Accord Healthcare S.L.U. Arsenic trioxide medac arsenic trioxide EMEA/H/C/005218 medac Gesellschaft für klinische Spezialpräparate mbH Trisenox arsenic trioxide EMEA/H/C/000388 Teva B.V. Arsenic trioxide Mylan arsenic trioxide EMEA/H/C/005235 Mylan Ireland Limited

Registration

Registration number: 66343-093
Registration status: Active
Dispensing: Over the counter
Route: ORAL

Sources

product · openFDA NDC · 66343-093 · Verified 2026-10-09 · open in source
registration_status · openFDA NDC · 66343-093 · Verified 2026-10-09 · open in source
ingredients.0 · openFDA NDC · 66343-093 · Verified 2026-10-09 · open in source
ingredients.1 · openFDA NDC · 66343-093 · Verified 2026-10-09 · open in source
ingredients.2 · openFDA NDC · 66343-093 · Verified 2026-10-09 · open in source
ingredients.3 · openFDA NDC · 66343-093 · Verified 2026-10-09 · open in source
ingredients.4 · openFDA NDC · 66343-093 · Verified 2026-10-09 · open in source